DEI/Trial Diversification
Sponsored
Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Workforce Compression in AI-Driven Clinical Trial Operations
2
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
3
ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise
4
ACT Brief: Site Cash Runway and Payment Infrastructure Priority, Biomarker Cut-Off Selection and Disparities, and Batch Failure Prevention Systems
5